OTC - ACTIVE INGREDIENT SECTION
Active ingredient
Aluminum Chlorohydrate 19.4%
Active ingredient
Aluminum Chlorohydrate 19.4%
Purpose
Antiperspirant
Use reduces underarm wetness
Warnings
For external use only
Flammable
Do not use on broken skin.
Stop use if rash or irritation occurs.
When using this product
Ask a doctor before use if you have kidney disease.
Use only as directed. Intentional misuse by deliberately concentrating and inhaling the contents can be harmful or fatal.
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
Directions
Inactive ingredients
Propellant (a blend of butane, hydrofluorocarbon 152a), Isopropyl Palmitate, Cyclopentasiloxane, Quaternium-90 Bentonite, Fragrance
ULTRA MAX
DRY SPAY
PEAK PERFORMANCE
Antiperspirant Deodorant
Motion Response Formula
GOES ON DRY, STAYS DRY
NEW WT. 4.0 OZ. (113g)
UMCN-00929-01P
ULTRA MAX
DRY SPRAY
CONFIDENCE
Antiperspirant Deodorant
Motion Response Formula
GOES ON DRY, STAYS DRY
NEW WT. 4.0 OZ. (113g)
UMCN-00930-01P
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ALUMINUM CHLOROHYDRATE | ACTIVE INGREDIENT | HPN8MZW13M | 1 | |
| ALUMINUM CHLOROHYDRATE | ACTIVE MOIETY | HPN8MZW13M | 1 | |
| BENTONITE | INACTIVE INGREDIENT | A3N5ZCN45C | 1 | |
| BUTANE | INACTIVE INGREDIENT | 6LV4FOR43R | 1 | |
| CYCLOMETHICONE 5 | INACTIVE INGREDIENT | 0THT5PCI0R | 1 | |
| ISOPROPYL PALMITATE | INACTIVE INGREDIENT | 8CRQ2TH63M | 1 | |
| QUATERNIUM-91 | INACTIVE INGREDIENT | 00J8H295NB | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 10237-922 | 10237-922-40 |
| 10237-923 | 10237-923-40 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| QUATERNIUM-91 | 00J8H295NB | IACT |
| ISOPROPYL PALMITATE | 8CRQ2TH63M | IACT |
| BENTONITE | A3N5ZCN45C | IACT |
| CYCLOMETHICONE 5 | 0THT5PCI0R | IACT |
| BUTANE | 6LV4FOR43R | IACT |
| ALUMINUM CHLOROHYDRATE | HPN8MZW13M | ACTIB |
| BUTANE | 6LV4FOR43R | IACT |
| ISOPROPYL PALMITATE | 8CRQ2TH63M | IACT |
| CYCLOMETHICONE 5 | 0THT5PCI0R | IACT |
| BENTONITE | A3N5ZCN45C | IACT |
| QUATERNIUM-91 | 00J8H295NB | IACT |
| ALUMINUM CHLOROHYDRATE | HPN8MZW13M | ACTIB |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| ISOPROPYL PALMITATE | ISOPROPYL PALMITATE | 8CRQ2TH63M | OINTMENT / TOPICAL | NA | ||
| BUTANE | BUTANE | 6LV4FOR43R | AEROSOL, FOAM / RECTAL | 12 mg | ||
| BUTANE | BUTANE | 6LV4FOR43R | AEROSOL / TOPICAL | NA | ||
| ISOPROPYL PALMITATE | ISOPROPYL PALMITATE | 8CRQ2TH63M | CREAM / TOPICAL | 112 mg | ||
| BENTONITE | BENTONITE | A3N5ZCN45C | SUPPOSITORY / VAGINAL | 288.1 mg | ||
| ISOPROPYL PALMITATE | ISOPROPYL PALMITATE | 8CRQ2TH63M | LOTION / TOPICAL | 5 %w/w | ||
| BENTONITE | BENTONITE | A3N5ZCN45C | SHAMPOO, SUSPENSION / TOPICAL | 3.25 %w/v | ||
| BENTONITE | BENTONITE | A3N5ZCN45C | SYSTEM / TRANSDERMAL | 9.86 mg | ||
| BENTONITE | BENTONITE | A3N5ZCN45C | CAPSULE / ORAL | ADJ PH | ||
| ISOPROPYL PALMITATE | ISOPROPYL PALMITATE | 8CRQ2TH63M | AEROSOL / TOPICAL | 397 mg | ||
| BENTONITE | BENTONITE | A3N5ZCN45C | LOTION / TOPICAL | 5 %w/w | ||
| CYCLOMETHICONE 5 | CYCLOMETHICONE 5 | 0THT5PCI0R | AEROSOL / TOPICAL | 2.5 %w/w | ||
| BENTONITE | BENTONITE | A3N5ZCN45C | TABLET, COATED / ORAL | 1.8 mg | ||
| ISOPROPYL PALMITATE | ISOPROPYL PALMITATE | 8CRQ2TH63M | GEL / TOPICAL | NA | ||
| CYCLOMETHICONE 5 | CYCLOMETHICONE 5 | 0THT5PCI0R | CREAM, AUGMENTED / TOPICAL | 260 mg | ||
| ISOPROPYL PALMITATE | ISOPROPYL PALMITATE | 8CRQ2TH63M | FILM, EXTENDED RELEASE / TRANSDERMAL | 187.5 mg | ||
| BUTANE | BUTANE | 6LV4FOR43R | AEROSOL, FOAM / TOPICAL | 27 %w/w | ||
| BENTONITE | BENTONITE | A3N5ZCN45C | POWDER / TOPICAL | 0.67 mg/mg | ||
| ISOPROPYL PALMITATE | ISOPROPYL PALMITATE | 8CRQ2TH63M | AEROSOL, SPRAY / TOPICAL | 397 mg | ||
| BENTONITE | BENTONITE | A3N5ZCN45C | SUSPENSION / ORAL | 65 mg/5ml | ||
| BENTONITE | BENTONITE | A3N5ZCN45C | TABLET / ORAL | 355 mg | ||
| BENTONITE | BENTONITE | A3N5ZCN45C | CREAM / TOPICAL | 4.1 %w/w | ||
| BENTONITE | BENTONITE | A3N5ZCN45C | POWDER, DENTIFRICE / DENTAL | 0.05 mg/mg | ||
| CYCLOMETHICONE 5 | CYCLOMETHICONE 5 | 0THT5PCI0R | AEROSOL, FOAM / TOPICAL | 144 mg | ||
| ISOPROPYL PALMITATE | ISOPROPYL PALMITATE | 8CRQ2TH63M | FILM / TRANSDERMAL | 2 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 98abc231-b625-e37c-e053-2a95a90afb70 | 2239e88a-142e-6136-e054-00144ff8d46c | 2019-12-01 | Warnings | 98abc231-b625-e37c-e053-2a95a90afb70 2239e88a-142e-6136-e054-00144ff8d46c |
Adverse event summaries are temporarily unavailable. Other product information remains available.